1. Wiedenmayer K, Summers RS, Mackie CA, Gaus AG, 
Everard M, Tromp D. The definition of Pharmaceutical 
care in Developing pharmacy practice, A focus on patient 
care. Geneva. World Health Organization and International 
Pharmaceutical Federation; 2006.
2. Saseen JJ, Carter BL. Hypertension. In: Dipiro JT, Talbert RL, 
Yee GC, Matzke GR, Wells BG, Posey LM, editors. 
Pharmacotherapy‑ A pathophysiologic approach, 6th ed. 
Newyork: McGraw‑Hill Companies; 2005. p. 185‑218.
3. Kearney PM, WheltonM, Reynolds K, Muntner P, Whelton PK, 
He J. Global burden of hypertension: Analysis of worldwide 
data. Lancet 2005;365:217‑23.
4. Lawes CM, Vander SH, Law MR, Elliott P, MacMahon S, 
Rodgers A. Blood pressure and the global burden of disease 
2000. Part II: Estimates of attributable burden. J Hypertens
2006;24:423‑30.
5. Brian BH. Therapy of hypertension. In: Laurance LB, John SL, 
Keith LP, editors. Goodman and Gilman’s the pharmacological 
Basis of therapeutics. 11th ed. New York: McGraw Hill; 2005 
p. 845.
6. Libby EA, Laub JJ. Economic and clinical impact of a pharmacy 
based antihypertensive replacement programme in primary 
care. Am J Health Syst Pharm 1997;54:2079‑83.
7. de Lyra DP, Kheir N, Abriata JP, da Rocha CE, Dos Santos CB, 
Pelá IR. Impact of Pharmaceutical Care interventions in the 
identification and resolution of drugrelated problems and 
on quality of life in a group of elderly outpatients in Ribeirão 
Preto (SP), Brazil. Ther Clin Risk Manag 2007;3:989‑98.
8. Sookaneknun P, Richard ME, Sanguansermsri J, Teerasut C. 
Pharmacist involvement in Primary Care Improves 
Hypertensive Patient Clinical Outcome. Ann Pharmacother 
2004;38:2023‑8.
9. Garcao JA, Cabrita J. Evaluation of a pharmaceutical care 
program for hypertensive patients in rural Portugal. J Am 
Pharm Assoc (Wash) 2002;42:858‑64.
10. Mancia G. Effective ambulatory blood pressure control in 
medical practice. Hypertension 2007;49:17‑8.
11. Chamontin B, Poggi L, Lang T, Ménard J, Chevalier H, 
Gallois H, et al. Prevelance, treatment, and control of 
hypertension in the French population data from a survey 
on high blood pressure in general practice. Am J Hypertens 
1994;11:759‑62.
12. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, 
Simons‑Morton DG, et al. Effects of diet and sodium intake 
on blood pressure: Subgroup analysis of the DASH – sodium 
trial. Ann Intern Med 2001;135:1019‑28.
13. DroyvoldWB, Midthjell K, Nilsen T, Holmen J. Change in body 
mass index and its impact on blood pressure: A prospective 
population study. Int J Obes (Lond) 2005;29:650‑5.
14. Carter BL, Billich AJ, Elliott WJ. How pharmacist can 
assist physicians with controlling blood pressure. J Clin 
Hypertens (Greenwich) 2003;5:31‑7.
15. Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to 
influence outcomes of hypertension therapy. Pharmacotherapy 
1997;17:140‑7.
16. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. 
The effect of clinical pharmacy services on patients with 
essential hypertension. Circulation 1973;48:1104‑11.
17. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist 
intervention and initiation of home blood pressure monitoring 
in patients with uncontrolled hypertension. Pharmacotherapy 
2000;20:1384‑9.
18. Ni Y, Chen Y, Huang W. The Effect of Pharmaceutical 
Care Programs on Blood Pressure Control in Individuals 
with Hypertension: A Meta‑Analysis. J Pharm Technol 
2009;25:292‑6.
19. Pickard AS, Johnson JA, Farris KB. The impact of pharmacist 
interventions on health related quality of life. J Ann 
Pharmacother 1999;33:1167‑72.
20. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm 
Assoc (Wash) 1996;36:443‑51.
21. Kusek JW, Lee JY, Smith DE, Milligan S, Faulkner M, 
Cornell CE, et al. Effect of blood pressure control and 
Antihypertensive drug regimen on quality of life: The African 
American study of kidney disease and hypertension (AASK) 
pilot study. Control Clin Trials 1996;16:40S‑6